Oxford Gene Technology Grants Microarray Licence to Febit
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Oxford Gene Technology (OGT) has announced that it has granted a microarray licence to febit biotech gmbh.
Dr Mike Evans, Chief Executive of OGT, said, “We are happy to support febit biotech’s technology by granting this licence and thus further the use of microarray technology”.
Peer Stähler, CSO of febit biotech gmbh said, “The agreement with OGT strengthens our IP and places us in a position to successfully market Geniom® worldwide”.
The acquired licence refers to the “Southern array patents”, fundamental patents covering the manufacture and use of DNA microarrays, and will remain valid for the patents’ lifetime.
